Craneware (LON:CRW) Hits New 52-Week Low After Analyst Downgrade

Shares of Craneware plc (LON:CRW) reached a new 52-week low on Tuesday after Berenberg Bank lowered their price target on the stock from GBX 2,600 to GBX 1,600. Berenberg Bank currently has a buy rating on the stock. Craneware traded as low as GBX 991 and last traded at GBX 1,034, with a volume of 332099 shares. The stock had previously closed at GBX 996.

Insiders Place Their Bets

In related news, insider Keith Neilson purchased 9,074 shares of Craneware stock in a transaction that occurred on Monday, July 6th. The stock was purchased at an average cost of GBX 1,102 per share, with a total value of £99,995.48. Also, insider Will Whitehorn acquired 640 shares of the firm’s stock in a transaction on Friday, July 3rd. The stock was bought at an average price of GBX 1,173 per share, with a total value of £7,507.20. Company insiders own 10.32% of the company’s stock.

Craneware Stock Up 3.8%

The stock has a market cap of £354.01 million, a PE ratio of 16.44 and a beta of 0.28. The business has a 50 day moving average of GBX 1,273.22 and a 200-day moving average of GBX 1,367.39. The company has a current ratio of 0.76, a quick ratio of 1.00 and a debt-to-equity ratio of 7.93.

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.